Cargando…
The treatment of Merkel cell carcinoma with immune checkpoint inhibitors: implications for patients with rheumatoid arthritis
OBJECTIVES: Merkel cell carcinoma (MCC) is a rare, highly aggressive neuroendocrine skin cancer, which typically affects elderly and immunocompromised and/or immunosuppressed patients. The checkpoint inhibitor avelumab, a mAb targeting the anti-programmed cell death ligand 1 (anti-PD-L1), has revolu...
Autores principales: | Klee, Gina, Kisch, Tobias, Kümpers, Christiane, Perner, Sven, Schinke, Susanne, Zillikens, Detlef, Langan, Ewan A, Terheyden, Patrick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8493100/ https://www.ncbi.nlm.nih.gov/pubmed/34622124 http://dx.doi.org/10.1093/rap/rkab037 |
Ejemplares similares
-
Disease Recurrence during Adjuvant Immune Checkpoint Inhibitor Treatment in Metastatic Melanoma: Clinical, Laboratory, and Radiological Characteristics in Patients from a Single Tertiary Referral Center
por: Kurzhals, Jonas K., et al.
Publicado: (2022) -
Generalized morphoea in the setting of combined immune checkpoint inhibitor therapy for metastatic melanoma: A case report
por: Langan, Ewan A., et al.
Publicado: (2021) -
Immune Cell Infiltration of the Primary Tumor, Not PD-L1 Status, Is Associated With Improved Response to Checkpoint Inhibition in Metastatic Melanoma
por: Kümpers, Christiane, et al.
Publicado: (2019) -
Sequential Treatment With Targeted and Immune Checkpoint Therapy in Patients With BRAF Positive Metastatic Melanoma: The Importance of Timing?
por: Grätz, Victoria, et al.
Publicado: (2019) -
The impact of the Covid-19 pandemic on quality of life in skin cancer patients
por: Kurzhals, Jonas K., et al.
Publicado: (2021)